Adam Havey, EVP, Biodefense Divison at Emergent BioSolutions Inc. (EBS), sold 36,298 shares at $31.50 ($1.1M) on 2015-06-15, disclosed to the SEC on 2015-06-17.
Scheduled sale ($1.1M) by EVP, Biodefense Divison under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.50 | 10,606 | $334K | 29.2% |
| 2 | $31.50 | 15,919 | $501K | 43.8% |
| 3 | $31.67 | 9,773 | $310K | 27.0% |
| Total | $31.55 avg | 36,298 | $1.1M | 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |